Eran Broshy Insider Trading Activity
Eran Broshy has been net-selling over the last 12 months with 0 purchases and 5 sales across 1 company.
TBPH is the most-traded position with 5 trades. The largest single transaction was a sale of TBPH for $546K on Nov 11, 2025.
Performance Scorecard
Forward stock performance after each transaction by Eran Broshy. Buy returns measure price movement after open-market purchases; sell-avoided measures the loss avoided after open-market sales. Success rate counts trades where the insider's direction was right.
| PERIOD | AVG BUY RETURN | AVG SELL AVOIDED | SUCCESS RATE | TRADES |
|---|---|---|---|---|
| 30 days | — | +3.3% | 80% | 5 |
| 90 days | — | -3.2% | 40% | 5 |
| 120 days | — | +23.5% | 100% | 5 |
Performance based on stock price movement after each transaction date. Past results do not predict future returns. Not financial advice.
Price & Trades
Pro: Trade MarkersTBPH · Theravance Biopharma, Inc.
🔒 Subscribe to see trade entries
Pro members see exactly when Eran Broshy bought and sold TBPH.
Upgrade to ProRecent Trades
| DATE | TICKER | TYPE | SHARES | PRICE | VALUE | Δ OWNED | ROLE | FILING |
|---|---|---|---|---|---|---|---|---|
Nov 26, 2025 Filed 3d late | TBPH | Sell | 14,000 | $20.00 | $280K | −18.9% | Director | |
Nov 26, 2025 Filed 3d late | TBPH | Sell | 15,501 | $20.00 | $310K | −25.7% | Director | |
Nov 11, 2025 | TBPH | Sell | 29,500 | $18.50 | $546K | −32.3% | Director | |
Nov 11, 2025 | TBPH | Sell | 15,500 | $17.00 | $264K | −25.1% | Director | |
Nov 11, 2025 | TBPH | Sell | 14,000 | $18.50 | $259K | −23.3% | Director |
Top Companies Traded
| TICKER | COMPANY | TRADES | TOTAL VOLUME |
|---|---|---|---|
| TBPH | Theravance Biopharma, Inc. | 5 | $1.7M |
Other insiders at Theravance Biopharma, Inc.
1 other tracked filer at TBPH.